S&P 500
7,376.86
+23.13
+0.31%
Dow
51,285.73
-237.37
-0.46%
Nasdaq
24,579.42
+264.42
+1.09%
NYSE Composite
23,950.37
-5.63
-0.02%
Russell 2000
2,754.11
+24.22
+0.89%
VIX
25.64
-2.54
-9.01%
VSTM · Verastem, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$8.41
-0.97
(-10.29%)
● At close: November 6 at 4:00:00 PM EDT
$8.45
+0.04
(+0.48%)
Overnight:
9:20:50 PM EDT
DAY'S RANGE
$8.41
$7.76
$8.74
52-WEEK RANGE
$8.41
$3.43
$10.82
What's happening
- VSTM is down 10.29% today, trading at $8.41. — Live quote
- Volume today (481,523) is well below its 3-month average of 3,131,940. (Finnhub fundamentals)
- Last quarter's EPS missed estimates: $-0.74 actual vs. $-0.47 estimated (-58.1%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 9
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-11-01 (16 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
VSTM
+8.94%
vs S&P 500
+1.11%
1-YEAR RETURN
VSTM
+6.05%
vs S&P 500
-3.64%
6-MONTH RETURN
VSTM
+41.11%
3-MONTH RETURN
VSTM
+24.78%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-11-05 (Q3 2026)
$-0.74
Est. $-0.47
MISS -58.1%
2026-07-26 (Q2 2026)
$-0.35
Est. $-0.44
BEAT +20.7%
2026-04-26 (Q1 2026)
$-0.37
Est. $-0.47
BEAT +21.3%
2026-01-26 (Q4 2025)
$-0.50
Est. $-0.55
BEAT +9.8%
Valuation Measures & Ratios
Enterprise Value4$845.0M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)10.28
Price / Book76.72
EV4 / Revenue9.65
EV4 / EBITDA—
Profit Margin-231.59%
Operating Margin-182.57%
Return on Equity (ROE8)-165.40%
Return on Assets (ROA9)-94.54%
Avg Volume (3M)3,131,940
Quarterly history (5 periods)
| Measure | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $813.4M | $377.4M | $421.6M | $643.7M | $173.6M |
| P/E | -3.33 | -1.93 | -1.98 | -3.21 | -1.57 |
| Price/Sales | 8.65 | 5.23 | — | — | — |
| Price/Book | 80.52 | 7.55 | 5.16 | -41.46 | 4.81 |
| EV/Revenue | 6.81 | 3.34 | — | — | — |
| ROE | -2420.60% | -391.54% | -260.64% | 1291.52% | -305.80% |
| ROA | -106.47% | -94.77% | -93.56% | -113.38% | -56.18% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short17,201,810
Change from Prior Settlement+14.95%
% of Float—
Days to Cover (Short Ratio)2.49
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-10-15. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 1775.4% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +6.1%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -231.6%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-11-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on VSTM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Sep '26 | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.0M | $40.1M | $18.7M | $11.2M | $2.1M | — | — | $10.0M |
| Operating income | -$75.2M | -$32.7M | -$44.9M | -$40.7M | -$43.8M | -$44.2M | -$37.0M | -$18.3M |
| Net income | -$74.7M | -$34.7M | -$36.6M | -$98.5M | -$25.9M | -$52.1M | -$24.0M | -$8.3M |
| EPS (diluted) | $-0.74 | $-0.35 | $-0.46 | $-1.35 | $-0.62 | $-0.96 | $-0.60 | $-0.31 |
| EPS (basic) | $-0.74 | $-0.35 | $-0.37 | $-1.35 | $-0.39 | $-0.96 | $-0.60 | $-0.31 |
| Operating margin | -$313 | -$82 | -$240 | -$362 | -$2.0K | — | — | -$183 |
| Net margin | -$311 | -$87 | -$196 | -$876 | -$1.2K | — | — | -$83 |
Balance sheet
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $229.6M | $206.5M | $227.8M | $246.4M | $176.9M | $196.3M | $131.7M | $101.5M |
| Total liabilities | $219.5M | $156.5M | $146.0M | $189.2M | $192.4M | $160.2M | $164.1M | $130.4M |
| Stockholders' equity | $10.1M | $50.0M | $81.8M | $57.2M | -$15.5M | $36.1M | -$32.4M | -$28.9M |
| Total current assets | $199.4M | $176.2M | $202.9M | $223.4M | $154.1M | $174.3M | $124.7M | $95.0M |
| Total current liabilities | $103.3M | $78.1M | $66.8M | $72.3M | $59.7M | $50.4M | $35.6M | $31.0M |
| Cash & equivalents | $172.8M | $136.4M | $165.6M | $205.0M | $137.7M | $164.3M | $117.6M | $88.8M |
| Marketable securities (current) | — | — | $16.1M | — | — | — | — | — |
| Inventory | $2.3M | $2.4M | $2.3M | $1.8M | $1.8M | $1.2M | — | — |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | — | — | — | — | $20.0K | $21.0K | $22.0K | $32.0K |
| Intangible assets | $15.6M | $15.9M | $16.1M | $16.4M | $16.7M | $15.6M | — | — |
| Other non-current assets | $12.0M | $11.6M | $5.7M | $6.1M | $5.3M | $5.4M | $5.5M | $4.9M |
| Accounts payable | $20.2M | $18.0M | $9.6M | $12.4M | $9.9M | $8.0M | $7.2M | $4.0M |
| Accrued liabilities | $70.7M | $54.2M | $51.0M | $54.0M | $44.7M | $38.1M | $25.4M | $26.0M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | $40.7M |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $9.0K | $9.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $4.0K |
| Retained earnings | -$1.31B | -$1.24B | -$1.20B | -$1.16B | -$1.13B | -$1.03B | -$1.01B | -$955.5M |
| Accumulated other comprehensive income (loss) | $10.2M | $8.0M | $8.6M | $5.2M | $2.5M | $5.3M | $6.6M | — |
Cash flow
| Line item | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$33.6M | -$43.9M | -$52.1M | -$30.0M | -$36.2M | -$32.7M | -$38.7M | -$25.1M |
| Investing cash flow | -$7.5M | $16.2M | -$16.0M | -$1.3M | -$8.3M | — | — | $0 |
| Financing cash flow | $77.5M | -$1.5M | $28.7M | $98.6M | $17.9M | $79.4M | $67.4M | $742.0K |
| Free cash flow | — | — | — | — | — | — | — | -$25.1M |
| Capital expenditures | — | — | — | — | — | — | — | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $3.7M | $3.4M | $2.0M | $2.0M | $2.2M | $3.4M | $1.8M | $2.0M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | -$19.0M | $18.7M | $1.3M | $2.1M | $4.6M | $2.1M | — | — |
| Change in inventory | -$145.0K | $109.0K | $454.0K | $39.0K | $626.0K | $1.2M | — | — |
| Change in accounts payable | $2.2M | $8.4M | -$2.8M | $3.9M | $497.0K | $848.0K | $3.2M | -$412.0K |
| Purchases of investments | $0 | $0 | $16.0M | — | — | — | — | — |
| Sales/maturities of investments | $0 | $16.2M | — | — | — | — | — | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | -$1.0K | $0 | $0 | $42.6M | — |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $30.9M | $10.0M | — | $2.6M | $2.1M |
| Operating income | -$170.1M | -$115.0M | -$92.1M | -$72.9M | -$61.4M |
| Net income | -$209.5M | -$130.6M | -$87.4M | -$73.8M | -$71.2M |
| EPS (diluted) | $-3.02 | $-3.66 | $-3.96 | $-4.57 | $-4.90 |
| EPS (basic) | $-3.02 | $-3.66 | $-3.96 | $-4.57 | $-4.90 |
| Operating margin | -$550 | -$1.1K | — | -$2.8K | -$3.0K |
| Net margin | -$678 | -$1.3K | — | -$2.8K | -$3.5K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $246.4M | $101.5M | $149.7M | $95.0M | $108.7M |
| Total liabilities | $189.2M | $130.4M | $71.2M | $47.7M | $21.1M |
| Stockholders' equity | $57.2M | -$28.9M | $57.4M | $47.4M | $87.6M |
| Total current assets | $223.4M | $95.0M | $143.7M | $92.9M | $105.7M |
| Total current liabilities | $72.3M | $31.0M | $26.4M | $21.7M | $18.6M |
| Cash & equivalents | $205.0M | $88.8M | $77.9M | $74.9M | $21.3M |
| Marketable securities (current) | — | — | — | — | — |
| Inventory | $1.8M | — | — | — | — |
| Marketable securities (non-current) | — | — | — | — | — |
| Property, plant & equipment | — | $32.0K | $37.0K | $92.0K | $210.0K |
| Intangible assets | $16.4M | — | — | — | — |
| Other non-current assets | $6.1M | $4.9M | $4.6M | $58.0K | $169.0K |
| Accounts payable | $12.4M | $4.0M | $7.2M | $4.9M | $2.3M |
| Accrued liabilities | $54.0M | $26.0M | $17.9M | $15.0M | $15.6M |
| Deferred revenue (current) | — | — | $327.0K | — | — |
| Other current liabilities | — | — | — | — | — |
| Long-term debt | — | $40.7M | $40.1M | $24.5M | — |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $8.0K | $4.0K | $3.0K | $2.0K | $19.0K |
| Retained earnings | -$1.16B | -$955.5M | -$824.9M | -$737.5M | -$663.7M |
| Accumulated other comprehensive income (loss) | $5.2M | — | $13.0K | — | $34.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$137.5M | -$104.8M | -$86.5M | -$63.7M | -$53.5M |
| Investing cash flow | -$9.6M | $60.0M | -$44.4M | $66.2M | $87.0K |
| Financing cash flow | $263.3M | $54.8M | $134.2M | $51.8M | $6.9M |
| Free cash flow | — | -$104.8M | — | — | -$53.7M |
| Capital expenditures | — | $28.0K | — | — | $196.0K |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $9.4M | $7.3M | $5.9M | $6.0M | $7.7M |
| Deferred income taxes | — | — | — | $0 | $0 |
| Change in accounts receivable | $8.8M | — | -$31.0K | -$485.0K | $277.0K |
| Change in inventory | $1.8M | — | — | — | — |
| Change in accounts payable | $8.4M | -$3.2M | $2.3M | $2.6M | $623.0K |
| Purchases of investments | — | — | $96.4M | $17.8M | $86.4M |
| Sales/maturities of investments | — | $60.0M | $52.0M | $84.0M | $86.7M |
| Debt issued | — | — | — | — | — |
| Debt repaid | $42.6M | — | $300.0K | — | — |
| Tax withholding on stock comp | — | — | — | — | $925.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding VSTM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers83.0%
Shares Outstanding100,116,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,192,447 | $35.1M | 9.18% | +48.4% | 2026-08-07 |
| ARMISTICE CAPITAL, LLC | 7,024,000 | $26.8M | 7.02% | +53.0% | 2026-08-14 |
| RTW INVESTMENTS, LP | 6,635,793 | $25.3M | 6.63% | +0.9% | 2026-08-14 |
| Deep Track Capital, LP | 5,740,850 | $21.9M | 5.73% | +0.0% | 2026-08-14 |
| State Street Corp | 5,133,859 | $19.6M | 5.13% | +46.0% | 2026-08-07 |
| Rosalind Advisors, Inc. | 3,986,509 | $15.2M | 3.98% | +86.4% | 2026-08-14 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,851,508 | $14.7M | 3.85% | +15.9% | 2026-06-30 |
| Nantahala Capital Management, LLC | 3,584,820 | $13.7M | 3.58% | +0.0% | 2026-08-14 |
| Stonepine Capital Management, LLC | 3,349,627 | $12.8M | 3.35% | +1.4% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,266,870 | $12.5M | 3.26% | +331.6% | 2026-06-30 |
| Foresite Capital Management VI LLC | 3,146,631 | $12.0M | 3.14% | +0.0% | 2026-08-14 |
| Goldman Sachs Group Inc | 2,721,178 | $10.4M | 2.72% | +83.4% | 2026-08-14 |
| BAKER BROS. ADVISORS LP | 2,499,338 | $9.5M | 2.50% | +327.4% | 2026-08-14 |
| Alyeska Investment Group, L.P. | 2,289,625 | $8.7M | 2.29% | +11.7% | 2026-08-14 |
| MILLENNIUM MANAGEMENT LLC | 2,078,003 | $7.9M | 2.08% | -13.8% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,074,145 | $7.9M | 2.07% | +20.8% | 2026-08-12 |
| AIGH Capital Management LLC | 1,927,000 | $7.4M | 1.92% | -3.6% | 2026-08-07 |
| Opaleye Management Inc. | 1,800,000 | $6.9M | 1.80% | +0.0% | 2026-08-14 |
| BALYASNY ASSET MANAGEMENT L.P. | 1,686,575 | $6.4M | 1.68% | +311.6% | 2026-08-13 |
| Qube Research & Technologies Ltd | 1,628,488 | $6.2M | 1.63% | +10.3% | 2026-08-14 |
| ACORN CAPITAL ADVISORS, LLC | 1,469,153 | $5.6M | 1.47% | +0.0% | 2026-08-14 |
| NEXTBio Capital Management LP | 1,306,800 | $5.0M | 1.31% | +0.0% | 2026-08-14 |
| Franklin Resources Inc | 1,105,021 | $4.2M | 1.10% | -0.1% | 2026-08-04 |
| Pinnacle Financial Partners, Inc. | 1,086,440 | $4.2M | 1.09% | +119.4% | 2026-08-14 |
| AQR CAPITAL MANAGEMENT LLC | 934,565 | $3.6M | 0.93% | +1314.6% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-12-16 to 2026-11-03
Recent transactions
- Insiders have net sold 74,303 shares over the last 182 days, across 0 purchases and 8 sales.
- Most recent: Paterson Dan (President and CEO) — Open market sale of 1,299 shares on 2026-11-03.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)74,303 sh(8 txns)
Net Shares-74,303
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Paterson Dan | President and CEO | Open market sale | 2026-11-03 | 1,299 |
| Calkins Daniel | Chief Financial Officer | Open market sale | 2026-10-01 | 2,566 |
| BAILEY MICHAEL P | Director | Grant / award | 2026-05-21 | 108,000 |
| Tollefson Karin Anna | Director | Grant / award | 2026-05-21 | 36,000 |
| Stuglik Brian M | Director | Grant / award | 2026-05-21 | 36,000 |
| Rowinsky Eric K | Director | Grant / award | 2026-05-21 | 36,000 |
| ROBERTSON MICHELLE | Director | Grant / award | 2026-05-21 | 36,000 |
| Kapur Anil | Director | Grant / award | 2026-05-21 | 36,000 |
| Bunn Paul A. | Director | Grant / award | 2026-05-21 | 36,000 |
| JOHNSON JOHN | Director | Grant / award | 2026-05-21 | 36,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-03 | Paterson Dan | President and CEO | Open market sale | 1,299 | $9.60 |
| 2026-10-01 | Paterson Dan | President and CEO | Open market sale | 44,121 | $8.00 |
| 2026-10-01 | Calkins Daniel | Chief Financial Officer | Open market sale | 2,566 | $8.00 |
| 2026-09-30 | Paterson Dan | President and CEO | Grant / award | 106,893 | $0.00 |
| 2026-09-30 | Calkins Daniel | Chief Financial Officer | Grant / award | 8,333 | $0.00 |
| 2026-09-21 | Calkins Daniel | Chief Financial Officer | Open market sale | 55 | $7.70 |
| 2026-08-03 | Paterson Dan | President and CEO | Open market sale | 1,302 | $5.81 |
| 2026-06-22 | Paterson Dan | President and CEO | Open market sale | 20,871 | $4.18 |
| 2026-06-22 | Calkins Daniel | Chief Financial Officer | Open market sale | 4,032 | $4.18 |
| 2026-06-22 | Calkins Daniel | Chief Financial Officer | Open market sale | 57 | $4.13 |
| 2026-05-21 | BAILEY MICHAEL P | Director | Grant / award | 108,000 | $0.00 |
| 2026-05-21 | Tollefson Karin Anna | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | Stuglik Brian M | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | Rowinsky Eric K | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | ROBERTSON MICHELLE | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | Kapur Anil | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | Bunn Paul A. | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-21 | JOHNSON JOHN | Director | Grant / award | 36,000 | $0.00 |
| 2026-05-04 | Paterson Dan | President and CEO | Open market sale | 806 | $5.82 |
| 2026-03-20 | Calkins Daniel | Chief Financial Officer | Grant / award | 57 | $5.74 |
| 2026-02-04 | Paterson Dan | President and CEO | Open market sale | 970 | $6.69 |
| 2026-01-21 | Calkins Daniel | Chief Financial Officer | Grant / award | 16,665 | $0.00 |
| 2026-01-21 | Paterson Dan | President and CEO | Grant / award | 213,785 | $0.00 |
| 2026-01-12 | Paterson Dan | President and CEO | Open market sale | 10,321 | $7.16 |
| 2026-01-12 | Calkins Daniel | Chief Financial Officer | Open market sale | 5,039 | $7.16 |
| 2025-12-24 | Calkins Daniel | Chief Financial Officer | Open market sale | 80 | $7.86 |
| 2025-12-16 | Stuglik Brian M | Director | Open market sale | 592 | $9.14 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-11-09 02:45 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-11-05 | 4 | 2026-11-03 | View on SEC.gov → |
| 2026-11-05 | 8-K | 2026-11-05 | View on SEC.gov → |
| 2026-11-05 | 10-Q | 2026-09-30 | View on SEC.gov → |
| 2026-10-14 | 8-K | 2026-10-14 | View on SEC.gov → |
| 2026-10-14 | 8-K | 2026-10-12 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-23 | 4 | 2026-09-21 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-03 | View on SEC.gov → |
Recent news
Headlines about VSTM (Verastem, Inc.). Links open the publisher — we don’t host full articles.
-
Verastem stock trades at 7.55 euros after Q3 update - ad-hoc-news.de
ad-hoc-news.de · 2026-11-08 -
Verastem, Inc. (VSTM) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-11-07 -
H.C. Wainwright raises Verastem stock price target to $20 on drug progress By Investing.com
Investing.com South Africa · 2026-11-07 -
What Verastem (VSTM) Said on Its Q3 Earnings Call
Yahoo · 2026-11-07 -
Verastem (VSTM) Q3 2026 Earnings Call Transcript
Yahoo · 2026-11-06 -
Verastem, Inc. (VSTM) stock price, news, quote and history
Yahoo Finance Singapore · 2026-11-06 -
Verastem (VSTM) Wins FDA Priority Review, Is The Stock Cheap Or Priced For More?
Yahoo · 2026-11-06 -
Verastem expects october financing and CO-PACK revenue to fund operations into first half of 2028
Seeking Alpha · 2026-11-06
No headlines in this category right now — try “All”.